These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 5121120)

  • 21. [Clinical studies on differential therapy of hypertension with dichlorophenylaminoimidazoline hydrochloride (Haemiton)].
    Seifert A; Hafemeister G; Kirchner D; Wöstenberg D; Tiedcke H; Ullmann W
    Dtsch Gesundheitsw; 1970 Dec; 25(50):2369-74. PubMed ID: 5509665
    [No Abstract]   [Full Text] [Related]  

  • 22. [Arterial hypertension, use of ST 155].
    Califano JE; Lissarrague VM; Ferraris JM; Beilis P
    Prensa Med Argent; 1968 May; 55(13):601-3. PubMed ID: 5669169
    [No Abstract]   [Full Text] [Related]  

  • 23. Tiamenidine, a centrally acting antihypertensive drug in essential hypertension [proceedings].
    Zamboulis C; Hossmann V; Dollery CT; Eckert H
    Br J Clin Pharmacol; 1979 Oct; 8(4):390P. PubMed ID: 508528
    [No Abstract]   [Full Text] [Related]  

  • 24. [Clinical experimentation with a new imidazoline derivative (ST155) in the treatment of arterial hypertension].
    Ferreira EB; Eichemberg R; Berlitz MF
    Hospital (Rio J); 1969 Jun; 75(6):2139-51. PubMed ID: 5311472
    [No Abstract]   [Full Text] [Related]  

  • 25. [First clinical experiences with a new hypotensive substance in severe forms of hypertension].
    Bergström J; Bergquist-Poppen M; Bucht H
    Arzneimittelforschung; 1966 Dec; 16(12):1606-10. PubMed ID: 6014792
    [No Abstract]   [Full Text] [Related]  

  • 26. [Clinical and hemodynamic study of a new antihypertensive agent].
    Palmero HA; Caeiro AE; Lussi H; Massari P; Amuchastegui S
    Prensa Med Argent; 1968 Aug; 55(25):1212-6. PubMed ID: 4885121
    [No Abstract]   [Full Text] [Related]  

  • 27. [ECG studies following oral administration of a new antihypertensive substance (Catapresan)].
    Strössenreuther H
    Med Monatsschr; 1966 Dec; 20(12):565-6. PubMed ID: 5980274
    [No Abstract]   [Full Text] [Related]  

  • 28. [Treatment with hypertension with catapresan].
    Votchal BE; Kuchkina TS; Abramova VG
    Vrach Delo; 1972 Sep; 9():21-4. PubMed ID: 4658108
    [No Abstract]   [Full Text] [Related]  

  • 29. [Clinico-experimental study of a hypotensive drug: 2(2,6-dichloro-phenylamino)-2-imidazoline hydrochloride].
    Caparello O; Contino A; Viola A; Pirro G
    Clin Ter; 1971 Jul; 57(6):553-62. PubMed ID: 5136489
    [No Abstract]   [Full Text] [Related]  

  • 30. [Clinical studies with the new antihypertensive agent Catapresan].
    Jüngling K
    Med Welt; 1968 Sep; 39():2105-13. PubMed ID: 4887319
    [No Abstract]   [Full Text] [Related]  

  • 31. [Continuous automatic recording of blood pressure after administration of a new antihypertensive substance].
    Haan D
    Arzneimittelforschung; 1966 Sep; 16(9):1180-3. PubMed ID: 6014739
    [No Abstract]   [Full Text] [Related]  

  • 32. [Effect of prolonged treatment with 2-(2,6-dichlorophenylamine)-2-imidazoline HCl on renal hemodynamics in arterial hypertension].
    Ludwig H
    Arzneimittelforschung; 1968 May; 18(5):600-4. PubMed ID: 5755891
    [No Abstract]   [Full Text] [Related]  

  • 33. [Antihypertensive effect of an imidazole derivative in a group of elderly patients].
    Piliego N; Marinazzo A; De Donno G; Pezzuto A
    Clin Ter; 1970 Nov; 55(3):219-25. PubMed ID: 5516886
    [No Abstract]   [Full Text] [Related]  

  • 34. [The use of catapresan in the treatment of arterial hypertension].
    Teodorescu P; Cîmpeanu A
    Med Interna (Bucur); 1970 Dec; 22(12):1475-86. PubMed ID: 5502468
    [No Abstract]   [Full Text] [Related]  

  • 35. Anti-hypertensive therapy by losartan. How effective is AT1 receptor blockade?
    Brunner HR
    J Hum Hypertens; 1995 Nov; 9(11):859-60. PubMed ID: 8583462
    [No Abstract]   [Full Text] [Related]  

  • 36. [The first clinical experience in Italy with angiotensin II receptor antagonists: results of a multicenter study on the efficacy and tolerance in arterial hypertension].
    Trimarco B
    Cardiologia; 1995 Dec; 40(12 Suppl 1):193-5. PubMed ID: 8998714
    [No Abstract]   [Full Text] [Related]  

  • 37. [Long-term antihypertensive therapy with moxonidine (cynt) in patients with insulin-independent diabetes mellitus].
    Lazebnik LB; Malichenko SB; Serebrov AN
    Ter Arkh; 1997; 69(6):59-64. PubMed ID: 9297279
    [No Abstract]   [Full Text] [Related]  

  • 38. Controlling blood pressure throughout the day: issues in testing a new anti-hypertensive agent.
    Weber MA; Neutel JM; Smith DH
    J Hum Hypertens; 1995 Nov; 9 Suppl 5():S29-35. PubMed ID: 8583478
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The evaluation of hypertensive patients' adherence to the pharmacological treatment of hypertension].
    Tomaszewski M; Lacka B; Zukowska-Szczechowska E; Grzeszczak W; Gosek K
    Wiad Lek; 1999; 52(11-12):573-80. PubMed ID: 10745694
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Safety and efficacy of moxonidine in mild to moderate hypertension.
    Jain S; Malhotra P; Kumari S; Varma S
    J Assoc Physicians India; 2001 Aug; 49():829-30. PubMed ID: 11837474
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.